Board Meetings for SPARC
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| SPARC | Sun Pharma Advanced Research Company Limited | 04 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| SPARC | Sun Pharma Advanced Research Company Limited | 29 Oct 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| SPARC | Sun Pharma Advanced Research Company Limited | 30 Jul 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters | |
| SPARC | Sun Pharma Advanced Research Company Limited | 08 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| SPARC | Sun Pharma Advanced Research Company Limited | 29 Jan 2018 | Results | inter alia, to consider and take on record, the unaudited financial results of the Company for the quarter and nine months ended December 31, 2017. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 27 Oct 2017 | Results | inter alia, to consider and take on record, the unaudited financial results of the Company for the quarter and half year ended September 30, 2017. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 05 Aug 2017 | Results | Inter alia, to consider and take on record, the unaudited financial results of the Company for the quarter ended June 30, 2017. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 05 May 2017 | Preferential issue | inter alia ,also consider a proposal for raising of additional funds by way of issue of equity shares / warrants convertible into equity shares of the Company on preferential basis to certain promoter/ non-promoter entities, subject to the receipt of necessary approvals including approval of the shareholders at an Extra ordinary general meeting, and to determine the issue price. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 05 May 2017 | Results | Inter alia, to consider and take on record, the audited financial results of the Company for the quarter and twelve months ended March 31, 2017. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 27 Jan 2017 | Results | inter alia, to consider and take on record, the un-audited financial results of the Company for the quarter and nine months ended December 31, 2017. Further, pursuant to the Company s Code of Internal Procedures and Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons shall be closed from January 17,2017 to January 31, 2017 (both days inclusive) in view of the above. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 28 Oct 2016 | Results | Inter alia, to consider and take on record, the un-audited financial results of the Company for the quarter and half year ended September 30, 2016. Further, kindly note that the trading window for trading by designated persons shall be closed from October 19, 2016 to November 02, 2016 (both days inclusive) in view of the above. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 29 Jul 2016 | Results | inter alia, to consider and take on record, the un-audited financial results of the Company for the quarter ended June 30, 2016. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 06 May 2016 | Results | to consider, inter alia, to consider and take on record, the audited financial results of the Company for the year ended March 31, 2016. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 05 Mar 2016 | Others | inter alia, to fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlemcnt and Record Date/ Book Closure Dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the Company. | |
| SPARC | Sun Pharma Advanced Research Company Limited | 03 Feb 2016 | Results | to consider, inter alia, the un-audited financial results of the Company for the quarter and nine months ended 31st December 2015. |